Empowering Early Innovation
Strategic pre-seed to Series B funding across Agrotech, Healthcare, Material Science, DeFi, and the Circular Economy — paired with direct distribution through our enterprise network.
UGF is a dual-arm investment firm — funding early innovation through Venture Capital and building enduring value through Private Equity. One network, deployed across both ends of the growth curve.
Strategic pre-seed to Series B funding across Agrotech, Healthcare, Material Science, DeFi, and the Circular Economy — paired with direct distribution through our enterprise network.
Middle-market buyouts, corporate recapitalizations, and growth equity for mature businesses with proven models — accelerated by hands-on operational transformation.
UGF® acts as a dual force in global markets — specialized capital for high-growth startups and mature middle-market enterprises. Our VC portfolio gains distribution through our enterprise buyers; our PE portfolio gains early access to automation and software built across the venture arm.
Our deployment structure follows a strict three-year lifecycle, optimized for startup growth from validation to exit.
Our Private Equity group builds sustainable value through direct, hands-on operational optimization.
Both arms draw on the same operating platform — a shared network that turns capital into momentum, whether you're a seed-stage founder or a mature enterprise preparing for its next chapter.
Direct access to our enterprise buyers and regional hubs across Dubai, Istanbul, and Tallinn — a commercial head start most capital can't offer.
Digital enablement, automation, and process redesign — the same value-creation toolkit that scales startups and transforms middle-market operations.
Executive recruitment, board support, and active mentorship — placing the right operators and directors alongside your capital.
Our VC companies supply automation to our PE holdings; our PE network opens distribution for our ventures. Two arms, compounding returns.
Filter by division to explore the target markets, criteria, and models behind each arm.
Transformative farming techniques, IoT sensors, biological plant health, and sustainable agricultural logistics.
Preventive digital medicine, biotechnology, early diagnostic systems, and anti-aging treatments.
Autonomous AI university operating systems, SphereAgent automation suites, SIS/ERP alternatives, and outcome-based evaluation engines.
Acquiring controlling stakes in mature engineering, manufacturing, and logistics companies to drive operational improvements.
Capital for profitable, high-performing businesses seeking to scale operations, acquire competitors, or enter new geographies.
Long-term investments in industrial real estate, logistics hubs, clean energy assets, and telecommunications infrastructure.
A selection of ventures and enterprises operating successfully across both arms — building on our history of 20+ exits across global markets.
Organic fertilizer solutions that enhance soil health and crop productivity while promoting sustainable, efficient farming practices.
Pioneering preventive healthcare and anti-aging solutions through advanced biotechnology and personalized medicine.
The AI operating system for higher education — 24 AI SphereAgents automating admissions, finance, HR, and scheduling. Co-developed with the Abu Dhabi School of Management.
Leading middle-market manufacturer of high-precision electronic equipment, optimized via UGF operational restructures and modern robotic tooling.
Regional logistics and warehouse distributor serving the Baltic and Nordic regions, upgraded with dynamic IoT routing and energy-efficient facilities.
An enterprise resource planning suite acquired via growth buyout, now expanding into MENA markets through UGF's Dubai distribution pipelines.
The Urban Palate — a fast-casual chain refining street food into an elevated dining brand. Scaling locations, supply chain, and operations through UGF's brand-building and expansion playbook.
Liquid® is UGF's proprietary, patented portfolio-management platform. Discover vetted opportunities across both arms, invest directly, track your holdings in real time, and cash in or out on demand — bringing genuine liquidity to assets that were never liquid before.
Since 2016, UGF has deployed capital across both arms with a consistent focus on durable, compounding value — not just growth at any cost.
“UGF didn't just fund Biofama — they opened distribution across three regions in our first year. That's the difference between capital and a platform.
“The operational team embedded with us from week one. Within eighteen months we'd automated production and doubled throughput without losing our culture.
“They understood the technology and the academic market. Co-developing Universitas with UGF's network is why we shipped 24 AI agents, not two.
A team spanning venture investing, private equity, and hands-on operations — aligned around a single platform and a long-term view.
Founded UGF in 2016 to bridge early innovation and mature enterprise value. Two decades across global capital markets.
Leads pre-seed to Series B investing across Agrotech, Healthcare, and AI. Former operator and three-time founder.
Runs middle-market buyouts and growth equity. Background in corporate restructuring and industrial operations.
Heads the cross-portfolio platform — distribution, automation, and talent — that both arms rely on.
Thank you — our venture team will review your submission and respond within 5–7 business days.
Notes on the markets we invest in, updates from the portfolio, and announcements from across both arms.
Get in touch with our division representatives across the markets we operate in.
This article is reserved for Liquid® account holders. Sign in with your platform credentials to continue.
Welcome back, member. You now have access to: